Racial disparities of open angle glaucoma: A study of mitochondria and oxidative stress in human trabecular meshwork
开角型青光眼的种族差异:人类小梁网线粒体和氧化应激的研究
基本信息
- 批准号:10735655
- 负责人:
- 金额:$ 54.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-30 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:8-hydroxy-2&apos-deoxyguanosineAccelerationAffectAfrican AmericanAfrican ancestryAgeAggressive courseAntioxidantsAqueous HumorB-LymphocytesBioenergeticsBiologicalBlack PopulationsBlack raceBlindnessBloodCell Culture TechniquesCellsClassificationComplexCorneaDNA MarkersDataDevelopmentDiseaseDisease ProgressionDisparityDrug Metabolic DetoxicationElementsExposure toEyeEye BanksFoundationsFree RadicalsFunctional disorderGene ExpressionGenesGeneticGenotypeGlaucomaGlutathioneGoalsGoniotomiesHaplogroupHigh PrevalenceHomeostasisHumanIn Situ HybridizationIndividualKnowledgeLinkMeasurementMeasuresMetabolismMetforminMitochondriaMitochondrial DNAMonkeysNiacinamideOpen-Angle GlaucomaOperative Surgical ProceduresOrganellesOxidation-ReductionOxidative StressOxidative Stress InductionOxygenOxygen ConsumptionPartial PressurePathogenesisPathway interactionsPatient Self-ReportPatientsPersonsPhysiologic Intraocular PressurePhysiologicalPopulation StudyPredispositionPreventionPrimary Open Angle GlaucomaProductionProtonsPublic HealthPublishingRNARaceReactive Oxygen SpeciesReportingResearchRiskRisk FactorsSeveritiesSpecimenStratificationStressSuperoxide DismutaseSystemTestingTherapeuticThickTissuesTrabecular meshwork structureVision researchVisual impairmentWestern BlottingWorkanterior chamberantioxidant enzymeaqueousblack patientcatalasecell injurydifferential expressiondisease disparityearly onsethuman studyimprovedinnovationinsightinterestmitochondrial metabolismmodifiable riskneuroprotectionnovelnovel therapeuticsnuclear factor-erythroid 2oxidative DNA damageoxidative damagepersonalized therapeuticprecision medicinepressurepreventprotein expressionracial differenceracial disparitysuperoxide dismutase 1transcriptome sequencingubiquinol
项目摘要
Project Abstract:
Understanding the pathogenesis of glaucoma, a leading cause of blindness worldwide, is an important goal
of vision research. As indicated in numerous population-based studies, individuals of African descent
develop glaucoma at an earlier age with increased severity and risk of blindness. Many studies have
identified oxidative damage to the trabecular meshwork (TM) cells, leading to decreased outflow facility and
increased intraocular pressure. Although the evidence linking oxidative damage to glaucoma is strong, the
causes of oxidative damage in glaucoma are not known. In the proposed studies, we will test the hypothesis
that oxidative damage to the TM is associated with basic genetic and physiologic differences in oxygen
metabolism leading to disparities in glaucoma based on racial background. Our hypothesis is based on
intraocular measurements of oxygen partial pressure (pO2) made in the human eye during surgery. We
identified strong correlations between pO2 and important risk factors for glaucoma, including central corneal
thickness and African-American/Black (B) heritage. In addition, measurements of a cell marker for DNA
oxidative damage were elevated in the aqueous humor of B patients with severe glaucoma compared to W
patients. Cultured TM cells from B healthy donors compared to W cells had altered energy (ATP) and
reactive oxygen species production, implicating the energy processing organelles, the mitochondria. Our
specific aims will test these hypotheses: (Aim 1) will evaluate differences in TM gene expression between B
and W donor controls and in patients at various glaucoma stages in order to identify the genetic basis of
disparities in tissue function (controlling eye pressure) and susceptibility to damage. Genes of interest will
be further studied (RT-qPCR, in situ hybridization) and delineate protein expression (Western blot) in the
tissue and potential biological pathways involved, focusing on mitochondrial function, oxidative stress and
antioxidant protection. (Aim 2A) will study mitochondrial functions in primary human TM cell cultures from
specimens of B and W healthy donor controls and glaucoma patients at various severity stages. We will
determine the effects of racial differences and exposure to varying levels of pO2 on detailed analyses of
mitochondrial quantities and function, reactive oxygen species levels and antioxidant protection. (Aim 2B)
will also assess the cellular effects of potential antioxidative therapies. The proposed research is innovative
because understanding these physiological mechanisms potentially contributing to disease disparity based
on racial ancestry, confirmed by blood and tissue ancestral genotyping and mitochondrial DNA haplogroup
stratification, will provide important information about the pathophysiology of open angle glaucoma by
identifying factors responsible for the TM dysfunction and loss of aqueous outflow facility. The knowledge
gained in these studies may lead to new therapies and strategies to prevent this blinding disease.
项目摘要:
了解青光眼的发病机制是一个重要的目标。青光眼是世界范围内致盲的主要原因
视觉研究的成果。正如许多基于人口的研究表明的那样,非洲人后裔
青光眼发病年龄较早,病情严重,失明风险较大。许多研究都有
确认小梁网(TM)细胞的氧化损伤,导致流出设施减少和
眼压升高。尽管将氧化损伤与青光眼联系在一起的证据很强,但
青光眼氧化损伤的原因尚不清楚。在拟议的研究中,我们将检验这一假设
TM的氧化损伤与氧气的基本遗传和生理差异有关
新陈代谢导致基于种族背景的青光眼差异。我们的假设是基于
手术中对人眼内氧分压(PO2)的测量。我们
PO2与包括中央角膜在内的青光眼的重要危险因素有很强的相关性
厚度和非裔美国人/黑人(B)传统。此外,对DNA细胞标志物的测量
与W组相比,B组重度青光眼患者房水中氧化损伤增加
病人。与W细胞相比,来自B健康供者的培养的TM细胞改变了能量(ATP)和
产生活性氧,牵涉到能量处理细胞器,即线粒体。我们的
特定的AIMS将检验这些假设:(AIM 1)将评估不同菌株之间TM基因表达的差异
和W供者对照以及不同青光眼阶段的患者,以确定遗传基础
组织功能(控制眼压)和损伤易感性的差异。感兴趣的基因将
进一步研究(RT-qPCR、原位杂交)和描绘蛋白表达(Western印迹)
组织和潜在的生物途径参与,重点是线粒体功能,氧化应激和
抗氧化保护。(Aim 2A)将研究原代人类TM细胞培养中的线粒体功能
B级和W级健康供者对照和不同严重程度的青光眼患者的标本。我们会
确定种族差异和暴露于不同水平的pO2对详细分析
线粒体数量和功能、活性氧水平和抗氧化保护。(目标2B)
还将评估潜在抗氧化疗法的细胞影响。建议的研究具有创新性。
因为了解这些可能导致疾病差异的生理机制
关于种族血统,由血液和组织祖先基因分型和线粒体DNA单倍群确认
分层,将提供有关开角型青光眼病理生理学的重要信息。
确定导致房水流出功能障碍和房水流出设施丧失的因素。《知识》
在这些研究中获得的成果可能会导致预防这种致盲疾病的新疗法和战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLA J SIEGFRIED其他文献
CARLA J SIEGFRIED的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLA J SIEGFRIED', 18)}}的其他基金
Racial Disparities in glaucoma: Implications of SDPR/Cavin2 in human trabecular meshwork
青光眼的种族差异:SDPR/Cavin2 对人类小梁网的影响
- 批准号:
9808499 - 财政年份:2019
- 资助金额:
$ 54.54万 - 项目类别:
Ocular Oxygen Metabolism and the Etiology of Open Angle Glaucoma
眼氧代谢与开角型青光眼的病因学
- 批准号:
8300074 - 财政年份:2011
- 资助金额:
$ 54.54万 - 项目类别:
Ocular Oxygen Metabolism and the Etiology of Open Angle Glaucoma
眼氧代谢与开角型青光眼的病因学
- 批准号:
8703109 - 财政年份:2011
- 资助金额:
$ 54.54万 - 项目类别:
Ocular Oxygen Metabolism and the Etiology of Open Angle Glaucoma
眼氧代谢与开角型青光眼的病因学
- 批准号:
8517126 - 财政年份:2011
- 资助金额:
$ 54.54万 - 项目类别:
Ocular Oxygen Metabolism and the Etiology of Open Angle Glaucoma
眼氧代谢与开角型青光眼的病因学
- 批准号:
8086516 - 财政年份:2011
- 资助金额:
$ 54.54万 - 项目类别:
相似海外基金
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
- 批准号:
10305569 - 财政年份:2021
- 资助金额:
$ 54.54万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Evaluation of Pharmaco-dynamics, Effects of Prior Standard of Care and A Human Phase 0 Study
GBM 中的 6-硫代-2-脱氧鸟苷:药效学评估、先前护理标准的影响和人类 0 期研究
- 批准号:
10488244 - 财政年份:2021
- 资助金额:
$ 54.54万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10305565 - 财政年份:2021
- 资助金额:
$ 54.54万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10488242 - 财政年份:2021
- 资助金额:
$ 54.54万 - 项目类别:
6-thio-2'-deoxyguanosine: A Novel Immunogenic Telomerase-Mediated Therapy in Glioblastoma - A Duke and UTSW Collaboration
6-硫代-2-脱氧鸟苷:一种新型免疫原性端粒酶介导的胶质母细胞瘤疗法 - 杜克大学和 UTSW 合作
- 批准号:
10488237 - 财政年份:2021
- 资助金额:
$ 54.54万 - 项目类别:
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
GBM 中的 6-硫代-2-脱氧鸟苷:作用机制、功效和生物标志物鉴定的临床前评估
- 批准号:
10305568 - 财政年份:2021
- 资助金额:
$ 54.54万 - 项目类别:
RUI: Chemical Investigations into the Bioactivity of the DNA Lesion 8-Oxo-2'-deoxyguanosine
RUI:DNA 损伤 8-Oxo-2-脱氧鸟苷生物活性的化学研究
- 批准号:
1903855 - 财政年份:2019
- 资助金额:
$ 54.54万 - 项目类别:
Standard Grant
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2017
- 资助金额:
$ 54.54万 - 项目类别:
Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2015
- 资助金额:
$ 54.54万 - 项目类别:
Discovery Grants Program - Individual
Toxicity and Biosensing Properties of C8-Aryl-Deoxyguanosine Adducts
C8-芳基-脱氧鸟苷加合物的毒性和生物传感特性
- 批准号:
311600-2013 - 财政年份:2014
- 资助金额:
$ 54.54万 - 项目类别:
Discovery Grants Program - Individual